Jun 13, 2026 · Science & Research Daily Digest
Science, space, biomed, and climate research highlights for June 13, 2026 — summaries, links, and brief commentary.
I. Space & Deep Space
1. Ax-4 crew mission delayed again over ISS Zvezda module issue; ISRO, NASA, and SpaceX coordinating
Summary:
Per multiple reports on June 13, 2026, the Axiom Space Ax-4 mission carrying Indian astronaut Group Captain Shubhanshu Shukla has been postponed again. NASA said on social media that, together with Axiom Space, it is delaying Ax-4's launch to the International Space Station (ISS); a new launch date will follow once a technical issue involving the Zvezda module is resolved. ISRO Chairman Dr. V. Narayanan confirmed close coordination with Axiom, NASA, and SpaceX, emphasizing safety and mission integrity. Originally set for May 29, the flight had been rescheduled multiple times through June 11; if it proceeds, Shukla would become the first Indian astronaut to visit the ISS.
Links:
Commentary:
Commercial crew operations are again coupled to aging ISS module reliability — India's first ISS flight timeline depends on Russian-segment hardware as much as launch windows.
2. ESA AI scan of 99.6 million Hubble cutouts confirms 1,300+ anomalies, 800+ previously undocumented
Summary:
Per ESA/Hubble and science media around June 13, 2026, ESA researchers David O'Ryan and Pablo Gómez used the neural-network tool AnomalyMatch to systematically search ~99.6 million image cutouts from the Hubble Legacy Archive (~7–8 arcseconds each), completing initial screening in ~2.5 days. Manual review of top candidates confirmed 1,300+ true anomalies, more than 800 of which had not appeared in prior scientific literature, including gravitational-lens arcs and interacting galaxies. Results appear in Astronomy & Astrophysics; the tool is available via ESA Datalabs and GitHub, offering a template for mining Euclid, Rubin, Roman, and other large surveys.
Links:
- ESA/Hubble — Researchers discover hundreds of cosmic anomalies with help from AI
- A&A — Identifying astrophysical anomalies in 99.6 million source cutouts from the Hubble legacy archive using AnomalyMatch
Commentary:
Classic survey archives still hide "known telescope, unknown objects" — future discovery rates may depend as much on compute and algorithms as on new apertures alone.
3. JWST plus gravitational lensing weighs dormant SMBH 10 billion light-years away at ~6 billion solar masses
Summary:
Per Carnegie Science, UCL releases, and Earth.com on June 13, 2026, an international team led by Andrew Newman used JWST stellar kinematics on galaxy MRG-M0138 at redshift ~2 to measure a dormant supermassive black hole of ~6 billion solar masses (6.0 × 10⁹ M☉, with uncertainties). At ~10 billion light-years, it is the most distant dormant black hole weighed via stellar dynamics — ~15× farther than the prior record. A foreground galaxy cluster magnifies the background ~30×, enabling star-speed measurements at cosmological distance. Published in Science (DOI: 10.1126/science.adx5816).
Links:
- EurekAlert — JWST measures mass of a dormant black hole from the early universe for the first time
- Science — A stellar dynamical mass measurement of an inactive black hole at redshift 2
Commentary:
A ~6-billion-solar-mass dormant black hole when the universe was ~3 Gyr old anchors early galaxy–black-hole co-evolution models and validates lensing+JWST dynamical measurements at high redshift.
II. Cosmology & Fundamental Research
4. European and Chinese teams report first working thorium-229 nuclear clocks with feedback-stabilized 148 nm transitions
Summary:
Per New Scientist, Science News, and arXiv preprints in June 2026, Thorsten Schumm's team at TU Wien with Germany's PTB embedded thorium-229 in CaF₂ crystals, locked a continuous-wave laser to the 148 nm nuclear transition with a feedback loop, and demonstrated a continuously running solid-state nuclear clock prototype stable for 24 hours without intervention — immediately applied to constrain ultralight dark matter. A Chinese team independently reported 229Th nuclear clock operation (arXiv:2606.08870). Nuclear clocks use nuclear rather than electronic transitions, promising greater robustness and potentially surpassing optical atomic clocks by orders of magnitude.
Links:
- New Scientist — First working nuclear clock heralds a new era in timekeeping
- arXiv — A thorium-229 optical nuclear clock with feedback loop
Commentary:
Two decades of chasing nuclear-transition timekeeping have moved from excitation spectroscopy to closed-loop clocks — metrology and dark-matter searches may soon share the same solid-state nuclear frequency standard.
5. Southampton-led reanalysis rebuts 2025 "cosmic slowdown" claim; Type Ia supernova cosmology confirms accelerating expansion
Summary:
Per ScienceDaily on June 13, 2026, and the Royal Astronomical Society, Phil Wiseman's University of Southampton team (including Adam Riess and Brian Schmidt) in Monthly Notices of the Royal Astronomical Society (DOI: 10.1093/mnras/stag797) re-examined Type Ia supernova cosmology, finding key errors in a 2025 Korean study claiming accelerating expansion was an illusion: host-galaxy age was mistaken for progenitor-star age, and standard host-galaxy mass corrections were omitted. With proper calibration, evidence for cosmic acceleration remains robust; dark energy as the leading framework stands.
Links:
- ScienceDaily — Dark energy survives major challenge as universe keeps accelerating
- Royal Astronomical Society — 'Crisis averted' as experts confirm universe's expansion IS accelerating
Commentary:
Controversial results forced a calibration-chain audit — the dark-energy "crisis" is averted for now, but the mechanism behind acceleration remains cosmology's biggest open question.
6. IonQ trapped-ion processor realizes ν = 1/3 fermionic Laughlin state, validating key topological observables
Summary:
Per Nature Communications published June 8, 2026 (DOI: 10.1038/s41467-026-72769-y), IonQ and collaborators prepared the ν = 1/3 fermionic Laughlin state on a 16-qubit circuit with 369 two-qubit gates, extracting correlation hole, bulk–edge correspondence, and topological entanglement entropy in strong agreement with exact diagonalization. The Laughlin state is a cornerstone of fractional charge, anyonic excitations, and incompressibility; bosonic analogs existed on simulators, but this is the first fermionic Laughlin demonstration on a quantum processor.
Links:
Commentary:
From topologically ordered phases hard to probe in materials to programmable hardware — an expandable path toward anyon physics and topological quantum information.
7. Nature Chemistry: End-capped-free carbyne chains show quasi-ballistic charge transport between Au electrodes
Summary:
Per Nature Chemistry online June 12, 2026 (DOI: 10.1038/s41557-026-02175-w), Morris et al. used transmetallation from Au(I) species to Au(0) electrodes to build one-dimensional carbon chains up to 16 atoms without end-capping groups, characterizing transport via scanning tunneling microscope break junctions. Shorter chains show oligoyne-like conductance decay with length; longer chains exhibit bond-length equalization toward cumulenic structure with markedly enhanced conductance; direct Au|C contact enables quasi-ballistic transport.
Links:
Commentary:
Linear carbon allotropes move from synthesis challenges to measurable conductance — a junction-stabilization route toward carbon-based 1D nanoelectronics.
III. Biomedicine & Health
8. World's first in vivo CRISPR Phase 3 success: single lonvo-z infusion cuts hereditary angioedema attacks 87%
Summary:
Per Intellia Therapeutics on June 13, 2026, and simultaneous New England Journal of Medicine publication, the global Phase 3 HAELO trial (80 HAE patients, randomized double-blind placebo-controlled) showed lonvoguran ziclumeran (lonvo-z, NTLA-2002) via single IV infusion reduced attack frequency 87% relative to placebo between weeks 5–28; 62% of treated patients were attack-free without maintenance therapy vs. 11% on placebo. The therapy inactivates KLKB1 to permanently lower kallikrein and bradykinin; results were presented in a late-breaking oral at EAACI 2026 in Istanbul. Intellia has initiated a rolling FDA BLA, targeting potential U.S. launch in H1 2027.
Links:
- Intellia Therapeutics — Additional Phase 3 HAELO Data at EAACI 2026, Published in NEJM
- Angioedema News — Lonvo-z gene-editing therapy lowers HAE attacks by 87% in trial
Commentary:
In vivo CRISPR crosses from proof-of-concept to positive Phase 3 — if approved, HAE could become the first "one dose, long remission" CRISPR indication template.
9. FDA grants accelerated approval to Sanofi Tzield for recently diagnosed stage 3 T1D in ages 8–17
Summary:
Per a Sanofi press release on June 13, 2026, the U.S. FDA granted accelerated approval to Tzield (teplizumab-mzwv) to delay decline in endogenous insulin production in children aged 8–17 recently diagnosed with stage 3 type 1 diabetes (T1D). Tzield is a CD3-directed antibody; approved in 2022 to delay stage 3 onset in stage 2 T1D, its indication expanded in April 2026 to include children from age 1 with stage 2 disease. It is also approved in the UK, EU (Teplizeld), China, Australia, and others for stage 2 delay; this approval fills the gap for disease modification after stage 3 diagnosis.
Links:
Commentary:
The T1D treatment window shifts from preventing stage 3 onset to slowing β-cell loss even after stage 3 diagnosis — immunomodulatory intervention moves later in the disease course.
10. T-CURX non-viral CAR-T TCX-001 wins Swissmedic Phase 1 approval for r/r AML and CLL targeting Siglec-6
Summary:
Per BioPharma Boardroom on June 13, 2026, Swiss biotech T-CURX received Swissmedic approval for a first-in-human Phase 1 trial of non-viral lead CAR-T TCX-001, starting at University Hospital Zürich with a planned CTIS filing to extend to four German sites via EMA. Up to 23 adults with relapsed/refractory acute myeloid leukemia (AML) or chronic lymphocytic leukemia (CLL), including transplant-ineligible patients, will be enrolled; primary endpoints are safety, tolerability, and dose-limiting toxicities. TCX-001 targets Siglec-6 via a scalable non-viral manufacturing process.
Links:
Commentary:
If clinically validated, non-viral CAR-T could materially cut cell-therapy COGS — Siglec-6 expands the AML/CLL immunotherapy map.
11. Incyte tafasitamab plus R-CHOP Phase 3 frontMIND prolongs PFS; EHA 2026 plenary presentation
Summary:
Per Incyte on June 13, 2026, the frontMIND Phase 3 study in previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and HGBL was presented at the EHA 2026 plenary in Stockholm: tafasitamab + lenalidomide + R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS) vs. R-CHOP, reducing progression or death risk 25% (HR 0.75, P = 0.0194; median follow-up 35.2 months); PFS benefit trends appeared across prespecified subgroups including COO molecular subtypes. Results were also published in The Lancet, supporting global regulatory filings.
Links:
Commentary:
First-line DLBCL gains a CD19 antibody plus immunomodulator on the R-CHOP backbone — a 25% PFS improvement is clinically meaningful; OS and long-term toxicity data remain pending.
IV. Climate, Energy & Environment
12. Rahmstorf team: Atlantic "cold blob" is AMOC slowdown signature; system approaching tipping point
Summary:
Per Phys.org and Eastern Herald on June 13, 2026, Stefan Rahmstorf's Potsdam Institute team in Geophysical Research Letters (DOI: 10.1029/2025gl118383) using reanalysis data finds cooling south of Greenland and Iceland is a depth-resolved signature of reduced ocean heat transport, not increased surface heat loss — surface heat loss in the region has actually decreased. AMOC is an IPCC climate tipping element; standard CMIP6 scenarios show tipping crossed around mid-century in a substantial subset of runs; authors say the system is close enough to warrant serious policy concern.
Links:
- Phys.org — Atlantic 'cold blob' caused by weakening ocean current system
- Geophysical Research Letters — Multidecadal Atlantic "Warming Hole" Heat Content Variations Are Caused by Ocean Heat Transport, Not by Surface Fluxes
Commentary:
The cold blob upgrades from phenomenon to AMOC-weakening observational fingerprint — long-term risks to European winters and fisheries are re-quantified.
13. Ambient-air perovskite/silicon tandems reach 31.72% efficiency; SAM interface engineering narrows inert-atmosphere gap
Summary:
Per Perovskite-Info on June 12, 2026, a UNIST, KAUST, CUHK-Shenzhen, and Forschungszentrum Jülich team used engineered self-assembled monolayer (SAM) interfaces with glutamate-derived ammonium (GDMA⁺) to fabricate 1.00 cm² wide-bandgap perovskite cells at 21.20% efficiency (Voc 1.28 V) in ambient air, and monolithic perovskite/silicon tandems at 31.72% (third-party certified 31.36%) — only ~0.9 percentage points below 32.60% under inert atmosphere. Unencapsulated tandems retained >92% initial efficiency after 600 h at 85°C in air and >90% after 1,000 h under AM1.5G illumination.
Links:
Commentary:
Tandem industrialization hinges partly on cleanroom dependence — reproducible ambient fabrication, if scaled, could materially lower GW-scale line capex.
Today's Summary
- Human spaceflight: Ax-4 delayed again on June 13 over ISS Zvezda module issues; India's first ISS astronaut timeline uncertain.
- Observational breakthroughs: JWST plus lensing weighs a dormant black hole 10 Gyr away; ESA AI mining of Hubble finds 800+ previously undocumented anomalies.
- Fundamental physics: European and Chinese teams run thorium-229 nuclear clocks; Type Ia supernova analysis confirms accelerating expansion; IonQ prepares fermionic Laughlin state; 1D carbyne quasi-ballistic transport in Nature Chemistry.
- Gene and cell therapy: lonvo-z becomes first positive Phase 3 in vivo CRISPR therapy; Tzield expands to stage 3 T1D; non-viral CAR-T TCX-001 and tafasitamab first-line lymphoma Phase 3 wins.
- Climate and energy: AMOC weakening explains the Atlantic cold blob with tipping warnings; ambient perovskite/silicon tandems exceed 31% efficiency.
Daily Framing:
Today in the science cycle is a "timekeeping and editing double-breakthrough day" — nuclear clocks and CRISPR Phase 3 reset metrology and gene-therapy milestones, cosmology and AMOC work reinforce (or warn on) existing paradigms through reanalysis and observational fingerprints, while AI archive mining and ambient tandem cells point to a research through-line of lowering cost via algorithms and process rather than hardware alone.
This digest is compiled from live web search and is for reference only; verify facts against the sources.
Date: June 13, 2026 (Saturday)